61825-165 : Doral 15 mg Oral Tablet
NDC: | 61825-165 |
Labeler: | Cutis Health, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Doral |
Dosage Form: | Oral Tablet |
Application #: | NDA018708 |
Rev. Date: | |
CSA Schedule: | CIV (US) [1] |
[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.
Appearance:
Markings: | 15;DORAL |
Shapes: |
Capsule |
Colors: |
Orange |
Size (mm): | 12 |
Segments: * | 2 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces. |
NDC Package Codes:
- 61825-165-10: 100 TABLET IN 1 BOTTLE (61825‑165‑10)
- 61825-165-30: 30 TABLET IN 1 BOTTLE (61825‑165‑30)
Active Ingredients:
- Quazepam
Dosage Strength:
- 15 mg
Inactive Ingredients:
- Powdered Cellulose
- Starch, Corn
- Fd&c Yellow No. 6
- Lactose
- Magnesium Stearate
- Silicon Dioxide
- Sodium Lauryl Sulfate
Pharmaceutical Classes:
- Benzodiazepine [EPC]
- Benzodiazepines [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 59547-310 Doral 15 mg Oral Tablet by Nuro Pharma, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 61822-0047Next: 61825-302 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.